The scandal surrounding alleged misdeeds in China by Britain’s largest drugs maker GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has now seen a secretly recorded sex tape thrown into the mix. But could this bizarre turn mark the bottom of the whole miserable episode for Glaxo shareholders?
Will The Sex Tape Be As Bad As It Gets For GlaxoSmithKline plc?
VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) under the spotlight.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.